Serum matrix metalloproteinase-13 as a diagnostic biomarker for cutaneous squamous cell carcinoma

BACKGROUND: A significant proportion of newly diagnosed patients with cutaneous squamous cell carcinoma (cSCC) have metastasis and eventually die of the disease, necessitating the exploration of novel biomarkers for early detection of cSCC aggressiveness, risk assessment and monitoring. Matrix metal...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hui, Li, Hong, Yan, Qingtao, Gao, Sumei, Gao, Jianfang, Wang, Zhenhua, Sun, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8284021/
https://www.ncbi.nlm.nih.gov/pubmed/34266392
http://dx.doi.org/10.1186/s12885-021-08566-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8284021/
https://www.ncbi.nlm.nih.gov/pubmed/34266392
http://dx.doi.org/10.1186/s12885-021-08566-1

Ejemplares similares